Information

Dear user, the application need JavaScript support. Please enable JavaScript in your browser.

English (EN)·Polski (PL)·Ukraiński (UK)
Go to the home page of the library Uniwersytet Ekonomiczny we Wrocławiu Link opens in a new window Library logo Prolib Integro - home pageUniwersytet Ekonomiczny we Wrocławiu

You search for a phrase ""HTLV-I Infections"" according to the criterion: Subject Terms

  Filters
Align
Showing 1-20 from 905 results
Title:
Geographic characteristics of HTLV-1 molecular subgroups and genetic substitutions in East Asia: Insights from complete genome sequencing of HTLV-1 strains isolated in Taiwan and Japan.
Authors:
Nozuma S; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
Yoshimura A; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
Pai SC; Division of Quality, Taipei Blood Center, Taipei, Taiwan.
Chen HJ; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan.
Matsuura E; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
Tanaka M; Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
Kodama D; Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
Dozono M; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
Matsuzaki T; Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
Takashima H; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Kagoshima, Japan.
Yang YC; Department of Clinical Laboratory Sciences and Medical Biotechnology, National Taiwan University College of Medicine, Taipei, Taiwan.
Kubota R; Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
Show more
Source:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Feb 05; Vol. 18 (2), pp. e0011928. Date of Electronic Publication: 2024 Feb 05 (Print Publication: 2024).
Publication Type:
Journal Article
MeSH Terms:
Human T-lymphotropic virus 1*
HTLV-I Infections*/epidemiology
Humans ; Japan/epidemiology ; Taiwan/epidemiology ; Phylogeny ; Bayes Theorem ; Sequence Analysis, DNA ; Asia, Eastern/epidemiology ; Whole Genome Sequencing
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers.
Authors:
Kameda T; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Utsunomiya A; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
Otsuka N; Youkikai Ikei Hospital, Kobayashi, Japan.
Kubuki Y; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Uchida T; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Shide K; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Kamiunten A; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Nakano N; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
Tokunaga M; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
Miyazono T; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
Ito Y; Department of Hematology, Imamura General Hospital, Kagoshima, Japan.
Yonekura K; Department of Dermatology, Imamura General Hospital, Kagoshima, Japan.
Kawakita T; National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
Akizuki K; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Tahira Y; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Karasawa M; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Hidaka T; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Konagata A; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Taniguchi N; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Nagatomo Y; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Kogo F; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Shimizu K; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Ueno H; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Ishizaki J; Department of Internal Medicine, Aisenkai Nichinan Hospital, Nichinan, Japan.
Takahashi N; Youkikai Ikei Hospital, Kobayashi, Japan.
Ikei Y; Youkikai Ikei Hospital, Kobayashi, Japan.
Hidaka M; National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
Yamaguchi H; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan.
Shimoda K; Division of Hematology, Diabetes, and Endocrinology, Department of Internal Medicine, Faculty of Medicine, University of Miyazaki, 5200 Kihara, Kiyotake, Miyazaki, 889-1692, Japan. .
Show more
Source:
BMC infectious diseases [BMC Infect Dis] 2024 Jan 17; Vol. 24 (1), pp. 96. Date of Electronic Publication: 2024 Jan 17.
Publication Type:
Observational Study; Multicenter Study; Journal Article
MeSH Terms:
Human T-lymphotropic virus 1*
COVID-19*/prevention & control
HTLV-I Infections*
Hypertension*
Diabetes Mellitus*
Dyslipidemias*
Humans ; Aged ; COVID-19 Vaccines ; Immunity, Humoral ; Prospective Studies ; Vaccination ; Immunoglobulin G ; Antibodies, Viral
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Analysis of Programmed Cell Death-1 (PD-1) Gene Variations (re11568821 and rs41386349) in HTLV-1 Infection Using One Primer Pair and Proviral Load.
Authors:
Hezave YA; Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, P.O. Box: 14665-1157, Iran.
Sharifi Z; Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, P.O. Box: 14665-1157, Iran. .
Kermani FR; Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, P.O. Box: 14665-1157, Iran.
Show more
Source:
Journal of molecular evolution [J Mol Evol] 2023 Aug; Vol. 91 (4), pp. 562-566. Date of Electronic Publication: 2023 Apr 05.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Human T-lymphotropic virus 1*/genetics
HTLV-I Infections*/genetics
HTLV-I Infections*/epidemiology
Humans ; Programmed Cell Death 1 Receptor/genetics ; Case-Control Studies ; Proviruses/genetics ; Apoptosis
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Epidemiological and molecular evidence of intrafamilial transmission through sexual and vertical routes in Bahia, the state with the highest prevalence of HTLV-1 in Brazil.
Authors:
Nunes da Silva A; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brasil.
Araújo THA; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brasil.
Boa-Sorte N; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brasil.
Farias G; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brasil.
Galvão-Barroso AK; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brasil.
de Carvalho A; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brasil.
Vicente AC; Instituto Oswaldo Cruz, Fundação Oswaldo Cruz, Rio de Janeiro, Brasil.
Galvão-Castro B; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brasil.; Laboratório Avançado de Saúde Pública, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brasil.
Rios Grassi MF; Escola Bahiana de Medicina e Saúde Pública, Salvador, Brasil.; Laboratório Avançado de Saúde Pública, Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, Brasil.
Show more
Source:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2023 Sep 28; Vol. 17 (9), pp. e0011005. Date of Electronic Publication: 2023 Sep 28 (Print Publication: 2023).
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Human T-lymphotropic virus 1*/genetics
HTLV-I Infections*/epidemiology
Infant ; Female ; Humans ; Brazil/epidemiology ; Prevalence ; Infectious Disease Transmission, Vertical ; Mothers
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
The transcriptome of HTLV-1-infected primary cells following reactivation reveals changes to host gene expression central to the proviral life cycle.
Authors:
Aristodemou AEN; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.
Rueda DS; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.; Single Molecule Imaging Group, MRC-London Institute of Medical Sciences, London, United Kingdom.
Taylor GP; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.
Bangham CRM; Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom.
Show more
Source:
PLoS pathogens [PLoS Pathog] 2023 Jul 31; Vol. 19 (7), pp. e1011494. Date of Electronic Publication: 2023 Jul 31 (Print Publication: 2023).
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Human T-lymphotropic virus 1*/physiology
HTLV-I Infections*
Humans ; Proviruses/genetics ; Transcriptome ; CD4-Positive T-Lymphocytes ; Viral Load ; Ubiquitin Thiolesterase/metabolism
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Mouse Models for HTLV-1 Infection and Adult T Cell Leukemia.
Authors:
Nakajima S; Department of Microbiology, Faculty of Medicine, Kansai Medical University, Hirakata 573-1010, Osaka, Japan.
Okuma K; Department of Microbiology, Faculty of Medicine, Kansai Medical University, Hirakata 573-1010, Osaka, Japan.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2023 Jul 21; Vol. 24 (14). Date of Electronic Publication: 2023 Jul 21.
Publication Type:
Journal Article; Review
MeSH Terms:
Leukemia-Lymphoma, Adult T-Cell*/metabolism
Human T-lymphotropic virus 1*/metabolism
HTLV-I Infections*
Adult ; Mice ; Humans ; Animals ; Retroviridae Proteins/metabolism ; Mice, Transgenic ; Disease Models, Animal ; Basic-Leucine Zipper Transcription Factors/metabolism
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Evaluation of human T-cell leukemia virus in vitro diagnostics using plasma specimens collected in Japan.
Authors:
Kusagawa S; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan. .
Kawana-Tachikawa A; AIDS Research Center, National Institute of Infectious Diseases, Tokyo, Japan.
Matsubayashi K; Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
Sobata R; Central Blood Institute, Blood Service Headquarters, Japanese Red Cross Society, Tokyo, Japan.
Hamaguchi I; Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo, Japan.
Show more
Source:
BMC infectious diseases [BMC Infect Dis] 2023 Jun 20; Vol. 23 (1), pp. 418. Date of Electronic Publication: 2023 Jun 20.
Publication Type:
Journal Article
MeSH Terms:
HTLV-I Infections*/diagnosis
Human T-lymphotropic virus 1*
Leukemia, T-Cell*
Humans ; Japan ; Human T-lymphotropic virus 2
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
CD30 Expression and Its Functions during the Disease Progression of Adult T-Cell Leukemia/Lymphoma.
Authors:
Nakashima M; Laboratory of Tumor Cell Biology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo 1088639, Japan.
Uchimaru K; Laboratory of Tumor Cell Biology, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, University of Tokyo, Tokyo 1088639, Japan.
Show more
Source:
International journal of molecular sciences [Int J Mol Sci] 2023 May 13; Vol. 24 (10). Date of Electronic Publication: 2023 May 13.
Publication Type:
Journal Article; Review
MeSH Terms:
Leukemia-Lymphoma, Adult T-Cell*/genetics
Lymphoma, Large-Cell, Anaplastic*/pathology
Hodgkin Disease*/pathology
Lymphoma, Large B-Cell, Diffuse*/pathology
Human T-lymphotropic virus 1*/metabolism
HTLV-I Infections*
Adult ; Humans ; Ki-1 Antigen/genetics ; Ki-1 Antigen/metabolism ; Disease Progression
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Human T-cell lymphotropic virus type 1 (HTLV-1) proposed vaccines: a systematic review of preclinical and clinical studies.
Authors:
Seighali N; Student Research Committee, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
Shafiee A; Student Research Committee, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.
Rafiee MA; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Aminzade D; School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Mozhgani SH; Department of Microbiology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran. .; Non-Communicable Disease Research Center, Alborz University of Medical Sciences, Karaj, Iran. .
Show more
Source:
BMC infectious diseases [BMC Infect Dis] 2023 May 11; Vol. 23 (1), pp. 320. Date of Electronic Publication: 2023 May 11.
Publication Type:
Systematic Review; Journal Article
MeSH Terms:
Human T-lymphotropic virus 1*
HTLV-I Infections*/prevention & control
Viral Vaccines*
Animals ; Humans ; T-Lymphocytes ; Vaccinia virus/genetics ; Peptides
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Putative role of HLA polymorphism among a Brazilian HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) population.
Authors:
Schor D; Laboratório de Imunologia e Imunogenética em Doenças Infecciosas, Instituto Nacional de Infectologia Evandro Chagas-INI/FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-900, Brazil.
Porto LC; Laboratório de Histocompatibilidade e Criopreservação, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, 20950-000, Brazil.
Roma EH; Laboratório de Imunologia e Imunogenética em Doenças Infecciosas, Instituto Nacional de Infectologia Evandro Chagas-INI/FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-900, Brazil. .
Castro-Alves J; Plataforma de Pesquisa Clínica, Instituto Nacional de Infectologia Evandro Chagas-INI/FIOCRUZ, Rio de Janeiro, RJ, 21040-900, Brazil.
Villela AP; Laboratório de Histocompatibilidade e Criopreservação, Universidade do Estado do Rio de Janeiro (UERJ), Rio de Janeiro, RJ, 20950-000, Brazil.
Araújo AQC; Laboratório de Pesquisa Clínica em Neuroinfecções, Instituto Nacional de Infectologia Evandro Chagas-INI/FIOCRUZ, Rio de Janeiro, RJ, 21040-900, Brazil.
Glória Bonecini-Almeida M; Laboratório de Imunologia e Imunogenética em Doenças Infecciosas, Instituto Nacional de Infectologia Evandro Chagas-INI/FIOCRUZ, Avenida Brasil, 4365, Manguinhos, Rio de Janeiro, RJ, 21040-900, Brazil.
Show more
Source:
Scientific reports [Sci Rep] 2023 May 11; Vol. 13 (1), pp. 7659. Date of Electronic Publication: 2023 May 11.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Paraparesis, Tropical Spastic*/genetics
HTLV-I Infections*/pathology
Human T-lymphotropic virus 1*/genetics
Humans ; Brazil ; Disease Progression ; HLA-A Antigens ; Viral Load
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Concluding Remarks for Special Issue HTLV-HIV Co-Infections.
Authors:
Vallejo A; Laboratory of Immunovirology, Infectious Diseases Department, Health Research Institute Ramon y Cajal (IRyCIS), Ramon y Cajal University Hospital, 28034 Madrid, Spain.
Abad-Fernández M; UNC HIV Cure Center, University of North Carolina, Chapel Hill, NC 27599, USA.
Show more
Source:
Viruses [Viruses] 2023 Apr 14; Vol. 15 (4). Date of Electronic Publication: 2023 Apr 14.
Publication Type:
Editorial
MeSH Terms:
Human T-lymphotropic virus 1*
HTLV-I Infections*/complications
Coinfection*
HIV Infections*/complications
Humans ; Human T-lymphotropic virus 2
Editorial & Opinion
Full Text  Link opens in a new window Full TextDetails
Title:
Efficacy of l-Arginine treatment in patients with HTLV-1-associated neurological disease.
Authors:
Nozuma S; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Matsuura E; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Tashiro Y; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Nagata R; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Ando M; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Hiramatsu Y; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Higuchi Y; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Sakiyama Y; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Hashiguchi A; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Michizono K; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Higashi K; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Matsuzaki T; Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
Kodama D; Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
Tanaka M; Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
Yamano Y; Division of Neurology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan.
Moritoyo T; Clinical Research Promotion Center, The University of Tokyo Hospital, Bunkyo-ku, Japan.
Kubota R; Division of Neuroimmunology, Joint Research Center for Human Retrovirus Infection, Kagoshima University, Kagoshima, Japan.
Takashima H; Department of Neurology and Geriatrics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan.
Show more
Source:
Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2023 Feb; Vol. 10 (2), pp. 237-245. Date of Electronic Publication: 2022 Dec 22.
Publication Type:
Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Human T-lymphotropic virus 1*
Paraparesis, Tropical Spastic*/drug therapy
HTLV-I Infections*
Humans ; Female ; Aged ; Male ; Postural Balance ; Time and Motion Studies
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Development and validation of a duplex real-time PCR for the rapid detection and quantitation of HTLV-1.
Authors:
Ji H; National Center for Clinical Laboratories, Institute of Geriatric Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.; Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, People's Republic of China.
Chang L; National Center for Clinical Laboratories, Institute of Geriatric Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.; Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, People's Republic of China.
Yan Y; National Center for Clinical Laboratories, Institute of Geriatric Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, People's Republic of China.; Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, People's Republic of China.
Wang L; National Center for Clinical Laboratories, Institute of Geriatric Medicine, Beijing Hospital, National Center of Gerontology, Chinese Academy of Medical Sciences, Beijing, People's Republic of China. .; Beijing Engineering Research Center of Laboratory Medicine, Beijing Hospital, Beijing, People's Republic of China. .; Graduate School, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, People's Republic of China. .
Show more
Source:
Virology journal [Virol J] 2023 Jan 17; Vol. 20 (1), pp. 9. Date of Electronic Publication: 2023 Jan 17.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Human T-lymphotropic virus 1*/genetics
HTLV-I Infections*/epidemiology
Humans ; Real-Time Polymerase Chain Reaction/methods ; Reproducibility of Results ; Human T-lymphotropic virus 2/genetics ; Proviruses/genetics ; Viral Load
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Development and Validation of a Rapid Screening Test for HTLV-I IgG Antibodies.
Authors:
Herrera BB; Division of Allergy, Immunology, Infectious Diseases, Department of Medicine, Child Health Institute of New Jersey, Rutgers Robert Wood Johnson Medical School, Rutgers University, New Brunswick, NJ 08901, USA.; Rutgers Global Health Institute, Rutgers University, New Brunswick, NJ 08901, USA.; Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02115, USA.
Mayoral R; Universidade Federal da Bahia, Salvador 40170-110, Brazil.
Brites C; Universidade Federal da Bahia, Salvador 40170-110, Brazil.
Show more
Source:
Viruses [Viruses] 2022 Dec 31; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 31.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Human T-lymphotropic virus 1*
Epstein-Barr Virus Infections*
COVID-19*
Metal Nanoparticles*
HTLV-I Infections*/diagnosis
Humans ; HTLV-I Antibodies ; Gold ; Herpesvirus 4, Human ; SARS-CoV-2 ; Deltaretrovirus
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
HTLV-1/2 in Indigenous Peoples of the Brazilian Amazon: Seroprevalence, Molecular Characterization and Sociobehavioral Factors Related to Risk of Infection.
Authors:
Abreu IN; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075-110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil.
Lima CNC; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075-110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil.
Sacuena ERP; Laboratório de Genética Humana e Médica, Universidade Federal do Pará, Belém 66075-110, Brazil.
Lopes FT; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075-110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil.
da Silva Torres MK; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075-110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil.
Santos BCD; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075-110, Brazil.
de Oliveira Freitas V; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075-110, Brazil.
de Figueiredo LGCP; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075-110, Brazil.
Pereira KAS; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075-110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil.
de Lima ACR; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075-110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil.
Brito WRDS; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075-110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil.
Botelho BJS; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075-110, Brazil.
Gonçalves JSS; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075-110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil.
Lima SS; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075-110, Brazil.
Vallinoto IMVC; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075-110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil.
Guerreiro JF; Laboratório de Genética Humana e Médica, Universidade Federal do Pará, Belém 66075-110, Brazil.
Ishak R; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075-110, Brazil.
Vallinoto ACR; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075-110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075-110, Brazil.
Show more
Source:
Viruses [Viruses] 2022 Dec 21; Vol. 15 (1). Date of Electronic Publication: 2022 Dec 21.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Human T-lymphotropic virus 1*/genetics
HTLV-II Infections*/epidemiology
HTLV-I Infections*/epidemiology
Male ; Humans ; Female ; Adult ; Middle Aged ; Human T-lymphotropic virus 2 ; Brazil/epidemiology ; Seroepidemiologic Studies ; Indigenous Peoples
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Human T-Cell Leukemia Virus Type 1-Related Diseases May Constitute a Threat to the Elimination of Human Immunodeficiency Virus, by 2030, in Gabon, Central Africa.
Authors:
Oloumbou EF; Unité des Infection Rétrovirales et Pathologies Associées, Centre International de Recherches Médicales de Franceville (CIRMF), Franceville BP 769, Gabon.
Engone-Ondo JD; Unité des Infection Rétrovirales et Pathologies Associées, Centre International de Recherches Médicales de Franceville (CIRMF), Franceville BP 769, Gabon.
Mamimandjiami Idam I; Unité des Infection Rétrovirales et Pathologies Associées, Centre International de Recherches Médicales de Franceville (CIRMF), Franceville BP 769, Gabon.
Moussavou-Boudzanga P; Unité des Infection Rétrovirales et Pathologies Associées, Centre International de Recherches Médicales de Franceville (CIRMF), Franceville BP 769, Gabon.
Mfouo-Tynga I; Unité des Infection Rétrovirales et Pathologies Associées, Centre International de Recherches Médicales de Franceville (CIRMF), Franceville BP 769, Gabon.
Mouinga-Ondeme A; Unité des Infection Rétrovirales et Pathologies Associées, Centre International de Recherches Médicales de Franceville (CIRMF), Franceville BP 769, Gabon.
Show more
Source:
Viruses [Viruses] 2022 Dec 16; Vol. 14 (12). Date of Electronic Publication: 2022 Dec 16.
Publication Type:
Systematic Review; Journal Article; Review; Research Support, Non-U.S. Gov't
MeSH Terms:
Human T-lymphotropic virus 1*
Acquired Immunodeficiency Syndrome*/complications
Coinfection*
HIV Infections*/drug therapy
HIV Infections*/epidemiology
HIV Infections*/complications
HIV-1*
HIV Seropositivity*
Leukemia, T-Cell*/complications
Opportunistic Infections*
HTLV-I Infections*
Humans ; Gabon/epidemiology
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Systemic cytokines and GlycA discriminate disease status and predict corticosteroid response in HTLV-1-associated neuroinflammation.
Authors:
Assone T; Laboratory of Medical Investigation LIM 56, Division of Dermatology and Institute of Tropical Medicine of Sao Paulo, Medical School, University of São Paulo, São Paulo, SP, Brazil.; Laboratory of Immunohematology and Forensic Hematology-LIM40, Department of Forensic Medicine, Medical Ethics, Social Medicine and Work, University of São Paulo Medical School, São Paulo, Brazil.; Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Menezes SM; Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
de Toledo Gonçalves F; Laboratory of Medical Investigation LIM 56, Division of Dermatology and Institute of Tropical Medicine of Sao Paulo, Medical School, University of São Paulo, São Paulo, SP, Brazil.; Laboratory of Immunohematology and Forensic Hematology-LIM40, Department of Forensic Medicine, Medical Ethics, Social Medicine and Work, University of São Paulo Medical School, São Paulo, Brazil.
Folgosi VA; Laboratory of Medical Investigation LIM 56, Division of Dermatology and Institute of Tropical Medicine of Sao Paulo, Medical School, University of São Paulo, São Paulo, SP, Brazil.; Laboratory of Immunohematology and Forensic Hematology-LIM40, Department of Forensic Medicine, Medical Ethics, Social Medicine and Work, University of São Paulo Medical School, São Paulo, Brazil.
da Silva Prates G; Laboratory of Medical Investigation LIM 56, Division of Dermatology and Institute of Tropical Medicine of Sao Paulo, Medical School, University of São Paulo, São Paulo, SP, Brazil.; Laboratory of Immunohematology and Forensic Hematology-LIM40, Department of Forensic Medicine, Medical Ethics, Social Medicine and Work, University of São Paulo Medical School, São Paulo, Brazil.
Dierckx T; Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Braz M; Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.; Programa de Pós-Graduação em Ciências da Saúde, Faculdade de Medicina da Bahia, Universidade Federal da Bahia, Salvador, Bahia, Brazil.
Smid J; Institute of Infectious Diseases 'Emilio Ribas' (IIER) de São Paulo, São Paulo, SP, Brazil.
Haziot ME; Institute of Infectious Diseases 'Emilio Ribas' (IIER) de São Paulo, São Paulo, SP, Brazil.
Marcusso RMN; Institute of Infectious Diseases 'Emilio Ribas' (IIER) de São Paulo, São Paulo, SP, Brazil.
Dahy FE; Institute of Infectious Diseases 'Emilio Ribas' (IIER) de São Paulo, São Paulo, SP, Brazil.
Vanderlinden E; Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Claes S; Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Schols D; Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Bruhn R; Vitalant Research Institute, San Francisco, CA, USA.; University of California San Francisco, San Francisco, CA, USA.
Murphy EL; Vitalant Research Institute, San Francisco, CA, USA.; University of California San Francisco, San Francisco, CA, USA.
Penalva de Oliveira AC; Institute of Infectious Diseases 'Emilio Ribas' (IIER) de São Paulo, São Paulo, SP, Brazil.
Daelemans D; Laboratory of Virology and Chemotherapy, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Vercauteren J; Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium.
Casseb J; Laboratory of Medical Investigation LIM 56, Division of Dermatology and Institute of Tropical Medicine of Sao Paulo, Medical School, University of São Paulo, São Paulo, SP, Brazil.; Laboratory of Immunohematology and Forensic Hematology-LIM40, Department of Forensic Medicine, Medical Ethics, Social Medicine and Work, University of São Paulo Medical School, São Paulo, Brazil.
Van Weyenbergh J; Laboratory of Clinical and Epidemiological Virology, Department of Microbiology, Immunology and Transplantation, Rega Institute for Medical Research, KU Leuven, Leuven, Belgium. .
Show more
Source:
Journal of neuroinflammation [J Neuroinflammation] 2022 Dec 08; Vol. 19 (1), pp. 293. Date of Electronic Publication: 2022 Dec 08.
Publication Type:
Journal Article
MeSH Terms:
Motor Disorders*/virology
Neuroinflammatory Diseases*/virology
HTLV-I Infections*/complications
Female ; Humans ; Bayes Theorem ; Cytokines ; Human T-lymphotropic virus 1 ; Interleukin-17 ; Interleukin-6 ; Leukocytes, Mononuclear
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Prevalence and Risk Factors for HTLV-1/2 Infection inRiverside and Rural Populations of the State of Pará.
Authors:
de Lima ACR; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075110, Brazil.
Lopes FT; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075110, Brazil.
de Oliveira Freitas V; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.
Assad MN; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.
de Sousa RS; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.
Gonçalves JSS; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075110, Brazil.
Gomes JLC; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.
Dos Santos BC; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.
Lima CNC; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075110, Brazil.
Abreu IN; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075110, Brazil.
Dos Santos Brito WR; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075110, Brazil.
Pereira KAS; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075110, Brazil.
da Silva Torres MK; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075110, Brazil.
Lima SS; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.
Aben-Athar CYU; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.
Guerreiro JF; Laboratório de Genética Humana e Médica, Universidade Federal do Pará, Belém 66075110, Brazil.
Cayres Vallinoto IMV; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075110, Brazil.
Vallinoto ACR; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075110, Brazil.
Feitosa RNM; Laboratório de Virologia, Universidade Federal do Pará, Belém 66075110, Brazil.; Programa de Pós-Graduação em Biologia de Agentes Infecciosos e Parasitários, Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém 66075110, Brazil.
Show more
Source:
Viruses [Viruses] 2022 Oct 15; Vol. 14 (10). Date of Electronic Publication: 2022 Oct 15.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
HTLV-I Infections*/diagnosis
HTLV-I Infections*/epidemiology
HTLV-II Infections*/diagnosis
HTLV-II Infections*/epidemiology
Human T-lymphotropic virus 1*/genetics
Female ; Humans ; Male ; Human T-lymphotropic virus 2/genetics ; Prevalence ; Risk Factors ; Rural Population
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
HTLV-1/2 Infection in Blood Donors from a Non-Endemic Area (Catalonia, Spain) between 2008 and 2017: A 10-Year Experience.
Authors:
Piron M; Banc de Sang i Teixits de Catalunya (Blood and Tissue Bank of Catalonia, BST), Transfusion Safety Laboratory, 08005 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREhd), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Salvador F; International Health Unit Vall d'Hebron-Drassanes, Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Caballero E; Laboratory of Microbiology, Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Sánchez-Montalvá A; International Health Unit Vall d'Hebron-Drassanes, Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Bes M; Banc de Sang i Teixits de Catalunya (Blood and Tissue Bank of Catalonia, BST), Transfusion Safety Laboratory, 08005 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREhd), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Casamitjana N; Banc de Sang i Teixits de Catalunya (Blood and Tissue Bank of Catalonia, BST), Transfusion Safety Laboratory, 08005 Barcelona, Spain.
Puig L; Banc de Sang i Teixits de Catalunya (Blood and Tissue Bank of Catalonia, BST), Transfusion Safety Laboratory, 08005 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREhd), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Molina I; International Health Unit Vall d'Hebron-Drassanes, Infectious Diseases Department, Vall d'Hebron University Hospital, PROSICS Barcelona, Universitat Autònoma de Barcelona, 08035 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, 28029 Madrid, Spain.
Sauleda S; Banc de Sang i Teixits de Catalunya (Blood and Tissue Bank of Catalonia, BST), Transfusion Safety Laboratory, 08005 Barcelona, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREhd), Instituto de Salud Carlos III, 28029 Madrid, Spain.; Vall d'Hebron Research Institute (VHIR), Vall d'Hebron University Hospital, 08035 Barcelona, Spain.
Show more
Source:
Viruses [Viruses] 2022 Sep 06; Vol. 14 (9). Date of Electronic Publication: 2022 Sep 06.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Blood Donors*
HTLV-I Infections*/diagnosis
HTLV-I Infections*/epidemiology
HTLV-II Infections*/diagnosis
HTLV-II Infections*/epidemiology
Human T-lymphotropic virus 1*/genetics
Adult ; Deltaretrovirus ; Female ; Human T-lymphotropic virus 2 ; Humans ; Male ; Spain/epidemiology
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Title:
Postural Adjustments in HTLV-1 Infected Patients during a Self-Initiated Perturbation.
Authors:
Almeida GCDS; Laboratory of Human Motricity Studies, Institute of Health Science, Federal University of Pará, Belém 66050-160, Brazil.; Tropical Medicine Institute, Federal University of Pará, Belém 66050-160, Brazil.
Azevedo HR; Laboratory of Human Motricity Studies, Institute of Health Science, Federal University of Pará, Belém 66050-160, Brazil.
Costa KHA; Laboratory of Human Motricity Studies, Institute of Health Science, Federal University of Pará, Belém 66050-160, Brazil.; Tropical Medicine Institute, Federal University of Pará, Belém 66050-160, Brazil.
Júnior ATVDC; Laboratory of Human Motricity Studies, Institute of Health Science, Federal University of Pará, Belém 66050-160, Brazil.; Tropical Medicine Institute, Federal University of Pará, Belém 66050-160, Brazil.
Garcez DR; University Hospital Bettina Ferro de Souza, Federal University of Pará, Belém 66075-110, Brazil.
Souza GDS; Tropical Medicine Institute, Federal University of Pará, Belém 66050-160, Brazil.; Neuroscience and Cell Biology Graduate Program (PPGNBC), Federal University of Pará, Belém 66075-110, Brazil.
Callegari B; Laboratory of Human Motricity Studies, Institute of Health Science, Federal University of Pará, Belém 66050-160, Brazil.; Tropical Medicine Institute, Federal University of Pará, Belém 66050-160, Brazil.
Show more
Source:
Viruses [Viruses] 2022 Oct 28; Vol. 14 (11). Date of Electronic Publication: 2022 Oct 28.
Publication Type:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Human T-lymphotropic virus 1*
Paraparesis, Tropical Spastic*
HTLV-I Infections*
Humans ; Postural Balance/physiology ; Muscle, Skeletal
Academic Journal
Full Text  Link opens in a new window Full TextDetails
Showing 1-20 from 905 results

We use cookies to help identify your computer so we can tailor your user experience, track shopping basket contents and remember where you are in the order process.